Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  OrganiGram Holdings Inc    OGI   CA68620P1018

ORGANIGRAM HOLDINGS INC (OGI)
Mes dernières consult.
Most popular
  Report  
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (CAD)
Sales 2018 26,0 M
EBIT 2018 -3,20 M
Net income 2018 -0,66 M
Finance 2018 211 M
Yield 2018 -
Sales 2019 110 M
EBIT 2019 25,0 M
Net income 2019 18,7 M
Finance 2019 138 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019 25,83
EV / Sales2018 12,5x
EV / Sales2019 3,63x
Capitalization 537 M
More Financials
Company
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana.Through Organigram Inc., its main focus is on the production of condition specific medical marijuana for patients in Canada.The company was founded on August 22, 2014 and is headquartered in Moncton, Canada. 
Sector
Pharmaceuticals
Calendar
08/02Earnings Release
More about the company
Surperformance© ratings of OrganiGram Holdings Inc
Trading Rating : - Investor Rating :
More Ratings
Latest news on ORGANIGRAM HOLDINGS INC
07/18Hemp CBD Products Offer a Natural Alternative to Synthetic-Derived Medicines
AQ
07/11Today's Research Reports on Emblem, OrganiGram, Oncolytics Biotech and Aptose..
AC
07/10ORGANIGRAM : Signs Strategic Supplier Agreement with Hiku Brands
AQ
07/05ORGANIGRAM : signs supply agreement with the Alberta Gaming, Liquor & Cannabis C..
AQ
06/29ORGANIGRAM : signs supply agreement with Manitoba Liquor & Lotteries
AQ
06/18ACOLOGY : Shares Pop 10% On Large Product Order From Organigram Holdings
AQ
06/08ORGANIGRAM : Orgranigram applauds Senate vote in support of Bill C-45
AQ
06/06ORGANIGRAM : Industry looks for 'creative ways' to brand legalized marijuana
AQ
06/05ORGANIGRAM : Announces Health Canada Licensing of Phase 3 Cultivation Expansion
AQ
06/04ORGANIGRAM : Enters into Non-Binding Term Sheet for 26% Equity Interest in Evian..
AQ
More news
Sector news : Alternative Medicine
09:06aBattle lines drawn as EU court weighs fate of gene-edited crops
RE
08:48aMERCK AND : to Cut Drug Prices Amid Pressure -- WSJ
DJ
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
07/19AMGEN : and Cedars-Sinai in Collaboration for 'Health-Care Quality'
DJ
07/19MERCK AND : to Limit Drug-Price Increases, Cut Some Prices
DJ
More sector news : Alternative Medicine
News from SeekingAlpha
07/17THE BAK PORTFOLIO : Canadian Weed Is Legal And The Green Rush Has Begun 
07/13NY Health Department calls for legalization of recreational pot 
07/13CANADIAN CANNABIS OUTLOOK : Winners And Losers In British Columbia 
07/09WEEKLY CANNABIS REPORT : Our Best Long And Short Ideas 
07/08Who Is Shorting Cannabis Stocks? 
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 6,82  CAD
Spread / Average Target 47%
EPS Revisions
Managers
NameTitle
Greg Engel Chief Executive Officer & Non-Independent Director
Peter Amirault Chairman
Jeff Purcell Vice President-Operations
Paolo de Luca Chief Financial Officer
Kenneth Mitton Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORGANIGRAM HOLDINGS INC405
BEIJING TONGRENTANG CO., LTD.9.96%7 169
CANOPY GROWTH CORP13.35%5 661
DONG-E-E-JIAO CO LTD--.--%5 063
HUTCHISON CHINA MEDITECH LIMITED-11.61%4 204
MEDRELEAF CORP26.74%2 109